619 related articles for article (PubMed ID: 2013587)
1. Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement. Comparison of low-molecular-weight heparin and unfractionated heparin.
Eriksson BI; Kälebo P; Anthymyr BA; Wadenvik H; Tengborn L; Risberg B
J Bone Joint Surg Am; 1991 Apr; 73(4):484-93. PubMed ID: 2013587
[TBL] [Abstract][Full Text] [Related]
2. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
[TBL] [Abstract][Full Text] [Related]
3. Prevention of deep vein thrombosis with low molecular-weight heparin in patients undergoing total hip replacement. A randomized trial. The German Hip Arthroplasty Trial (GHAT) Group.
Arch Orthop Trauma Surg; 1992; 111(2):110-20. PubMed ID: 1314065
[TBL] [Abstract][Full Text] [Related]
4. Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group.
Colwell CW; Spiro TE; Trowbridge AA; Morris BA; Kwaan HC; Blaha JD; Comerota AJ; Skoutakis VA
J Bone Joint Surg Am; 1994 Jan; 76(1):3-14. PubMed ID: 8288662
[TBL] [Abstract][Full Text] [Related]
5. Prevention of thromboembolism with use of recombinant hirudin. Results of a double-blind, multicenter trial comparing the efficacy of desirudin (Revasc) with that of unfractionated heparin in patients having a total hip replacement.
Eriksson BI; Ekman S; Lindbratt S; Baur M; Bach D; Torholm C; Kälebo P; Close P
J Bone Joint Surg Am; 1997 Mar; 79(3):326-33. PubMed ID: 9070519
[TBL] [Abstract][Full Text] [Related]
6. Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.
Leyvraz PF; Bachmann F; Hoek J; Büller HR; Postel M; Samama M; Vandenbroek MD
BMJ; 1991 Sep; 303(6802):543-8. PubMed ID: 1655136
[TBL] [Abstract][Full Text] [Related]
7. Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin.
Levine MN; Hirsh J; Gent M; Turpie AG; Leclerc J; Powers PJ; Jay RM; Neemeh J
Ann Intern Med; 1991 Apr; 114(7):545-51. PubMed ID: 1848054
[TBL] [Abstract][Full Text] [Related]
8. Low molecular weight heparin (enoxaparin) compared with unfractionated heparin in prophylaxis of deep venous thrombosis and pulmonary embolism in patients undergoing hip replacement.
Avikainen V; von Bonsdorff H; Partio E; Kaira P; Hakkinen S; Usenius JP; Kaaja R
Ann Chir Gynaecol; 1995; 84(1):85-90. PubMed ID: 7645915
[TBL] [Abstract][Full Text] [Related]
9. Prevention of postoperative venous thrombosis: a randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement.
Planes A; Vochelle N; Mazas F; Mansat C; Zucman J; Landais A; Pascariello JC; Weill D; Butel J
Thromb Haemost; 1988 Dec; 60(3):407-10. PubMed ID: 2853459
[TBL] [Abstract][Full Text] [Related]
10. Prophylaxis for the prevention of venous thromboembolism after total knee arthroplasty. A comparison between unfractionated and low-molecular-weight heparin.
Faunø P; Suomalainen O; Rehnberg V; Hansen TB; Krøner K; Soimakallio S; Nielsen E
J Bone Joint Surg Am; 1994 Dec; 76(12):1814-8. PubMed ID: 7989386
[TBL] [Abstract][Full Text] [Related]
11. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement.
Bergqvist D; Benoni G; Björgell O; Fredin H; Hedlundh U; Nicolas S; Nilsson P; Nylander G
N Engl J Med; 1996 Sep; 335(10):696-700. PubMed ID: 8703168
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment. ENOXACAN Study Group.
Br J Surg; 1997 Aug; 84(8):1099-103. PubMed ID: 9278651
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the use of a foot pump with the use of low-molecular-weight heparin for the prevention of deep-vein thrombosis after total hip replacement. A prospective, randomized trial.
Warwick D; Harrison J; Glew D; Mitchelmore A; Peters TJ; Donovan J
J Bone Joint Surg Am; 1998 Aug; 80(8):1158-66. PubMed ID: 9730125
[TBL] [Abstract][Full Text] [Related]
14. Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery. The European Fraxiparin Study (EFS) Group.
Br J Surg; 1988 Nov; 75(11):1058-63. PubMed ID: 2905187
[TBL] [Abstract][Full Text] [Related]
15. Dihydroergotamine/heparin in the prevention of deep-vein thrombosis after total hip replacement. A controlled, prospective, randomized multicenter trial.
Beisaw NE; Comerota AJ; Groth HE; Merli GJ; Weitz HH; Zimmerman RC; Diserio FJ; Sasahara AA
J Bone Joint Surg Am; 1988 Jan; 70(1):2-10. PubMed ID: 3275673
[TBL] [Abstract][Full Text] [Related]
16. The prevention of postoperative deep vein thrombosis and pulmonary embolism with low dose subcutaneous heparin and dextran.
Verstraete M
Surg Gynecol Obstet; 1976 Dec; 143(6):981-5. PubMed ID: 996722
[TBL] [Abstract][Full Text] [Related]
17. A short course of low-molecular-weight heparin to prevent deep venous thrombosis after elective total hip replacement.
Gallay S; Waddell JP; Cardella P; Morton J
Can J Surg; 1997 Apr; 40(2):119-23. PubMed ID: 9126125
[TBL] [Abstract][Full Text] [Related]
18. [Different effectiveness of two preparations of low molecular weight heparin in patients with elective hip joint replacement].
Weber U; Koppenhagen K; Mälzer H; Matthes M
Langenbecks Arch Chir; 1991; 376(3):147-51. PubMed ID: 1651434
[TBL] [Abstract][Full Text] [Related]
19. Prevention of deep-vein thrombosis after total hip arthroplasty. Comparison of warfarin and dalteparin.
Francis CW; Pellegrini VD; Totterman S; Boyd AD; Marder VJ; Liebert KM; Stulberg BN; Ayers DC; Rosenberg A; Kessler C; Johanson NA
J Bone Joint Surg Am; 1997 Sep; 79(9):1365-72. PubMed ID: 9314399
[TBL] [Abstract][Full Text] [Related]
20. Phlebographic findings in venous thrombosis following total hip replacement.
Kälebo P; Anthmyr BA; Eriksson BI; Zachrisson BE
Acta Radiol; 1990 May; 31(3):259-63. PubMed ID: 2167109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
